|
⚲
|
| Keyboard |
| Peter Schultz | |
|---|---|
| Firm | |
| Address | c/o Reset Therapeutics, Inc 260 Littlefield Avenue, Suite 200 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Reset Therapeutics Inc | 021-257764 | Director | 29.7 M of 47.2 M |
||
| Ardelyx Inc | 021-242234 | Director | 77.8 M of 108.0 M |
||
| Reset Therapeutics Inc | 021-221749 | Director | 9.1 M of 12.0 M |
||
| Reset Therapeutics Inc | 021-207293 | Director | 14.8 M of 16.0 M |
||
| Wildcat Discovery Technologies Inc | 021-179795 | Director | 0.2 M of 0.2 M |
||
| Wildcat Discovery Technologies Inc | 021-163268 | Director | 13.5 M of 13.5 M |
||
| Ardelyx Inc | 021-162407 | Director | 17.6 M of 22.3 M |
||
| Ardelyx Inc | 021-151534 | Director | 5.0 M of 10.0 M |
||
| Ambrx Inc | 021-58840 | Director | 10.0 M of 10.0 M |
||